-
Pertussis Toxin as a Translational Immune Probe
2026-09-15
Pertussis toxin is more than a conventional immunology reagent: it is a controlled cAMP-linked perturbation tool that can help researchers dissect dendritic-cell responses, contextualize microglial biology, and design stronger translational studies around the TREM2–ERK/p38 axis.
-
LRPPRC–Dasatinib Dual OXPHOS Disruption
2026-09-15
A 2026 study identified dasatinib as a synergistic partner for LRPPRC inhibition through complementary suppression of nuclear- and mitochondrial genome-encoded OXPHOS genes. The findings provide a mechanistic rationale for combination strategies in LRPPRC-high tumors while remaining limited to preclinical cancer-cell models.
-
Human iPSC Sensory Neurons Model HSV-1 Latency
2026-09-14
Oh et al. developed a scalable human induced pluripotent stem cell-derived sensory neuron system that supports HSV-1 latency and experimentally induced reactivation. The model combines neuronal functional validation with virological and chromatin-based criteria, providing a more human-relevant platform for studying latent infection than conventional nonhuman systems alone.
-
H2S Deficiency and ER Stress in Diabetic Cardiomyopathy
2026-09-14
The reference study identifies reduced endogenous hydrogen sulfide production as a component of palmitate-associated cardiac lipotoxicity and links this deficit to endoplasmic reticulum stress. Its combined patient, animal, and AC16-cell experiments suggest that restoring H2S signaling can reduce lipid accumulation, apoptosis, and myocardial injury, while also defining practical boundaries for translating the findings into live-cell assays.
-
Kanamycin Sulfate for Reproducible Microbiology
2026-09-13
Kanamycin Sulfate provides a practical selection pressure for plasmid-bearing bacteria while also serving as a controlled variable in antibiotic resistance research. This guide connects preparation, selection, troubleshooting, and microbiota-aware assay design with insights from recent C. difficile toxin research.
-
DOPE Workflows for Nucleic Acid Delivery
2026-09-12
DOPE is a membrane-fusion helper that can improve endosomal escape in cationic liposomes and LNPs, while also serving as a defined phosphatidylethanolamine perturbation in fungal lipid-peroxidation assays. This guide connects formulation design, rice blast mechanistic experiments, and practical troubleshooting without treating delivery performance as proof of a ferroptosis mechanism.
-
LAG-3–TCR Proximity Suppresses T Cells and Autoimmunity
2026-09-12
The 2025 Cell study shows that LAG-3-mediated suppression depends on spatial proximity to the T cell receptor (TCR), rather than on MHC class II binding or CD4 proximity alone. Its mechanistic and therapeutic experiments connect LAG-3–TCR proximity to CD3ε/Lck disruption and establish a TCR/LAG-3 bispecific antibody as a strategy for suppressing pathogenic T cells in autoimmune disease models.
-
Tankyrase Inhibition in Hepatocellular Carcinoma
2026-09-11
Jia et al. showed that selective tankyrase inhibition restrains hepatocellular carcinoma cell growth while suppressing YAP/TEAD activity and increasing the inhibitory angiomotin-like proteins AMOTL1 and AMOTL2. The study is notable because it connects tankyrase activity to Hippo-pathway regulation, extending mechanistic analysis beyond the better-known Wnt/β-catenin axis.
-
GANT61: Practical GLI Inhibitor Workflows
2026-09-11
GANT61 provides a tractable way to test whether GLI1/2 activity drives proliferation, transcriptional remodeling, or treatment resistance. This guide connects concentration-controlled cell assays with tumor–immune experiments inspired by recent findings on GLI2, WNT signaling, prostaglandins, and immunotherapy resistance.
-
Dual-Action Inhibitors and p38α Dephosphorylation
2026-09-10
The reference preprint shows that selected p38α kinase inhibitors can do more than block catalysis: they can also accelerate WIP1-mediated dephosphorylation by stabilizing a phosphatase-accessible activation-loop conformation. This structure-guided concept provides a mechanistic framework for interpreting inhibitor potency and selectivity in inflammatory signaling research.
-
AP-2α–MGMT Control of TMZ Resistance in Recurrent GBM
2026-09-10
The reference study identifies AP-2α as a transcriptional suppressor of MGMT in recurrent glioblastoma and shows that restoring AP-2α activity improves temozolomide-associated DNA damage. Its combination of promoter-binding evidence, resistant-cell models, and an intracranial relapse model connects transcriptional regulation with therapeutic response and suggests a framework for studying MGMT-dependent TMZ resistance.
-
BI 2536: A Mechanistic Guide to PLK1 Checkpoints
2026-09-09
BI 2536 is a selective PLK1 inhibitor that connects mitotic checkpoint biochemistry with measurable G2/M arrest and apoptosis. This guide shows how to design assays that distinguish direct checkpoint effects from downstream loss of tumor-cell proliferation.
-
NVP-BGJ398 Phosphate: FGFR Assay Workflows
2026-09-09
NVP-BGJ398 phosphate supports mechanism-focused FGFR1–3 inhibition studies in cancer models and extends into FGFR3-driven skeletal disease research. This guide translates published findings into practical cell, signaling, tissue, and troubleshooting workflows.
-
Protease Inhibitor Cocktail for OXPHOS Workflows
2026-09-08
Protect intact LRPPRC and OXPHOS proteins during cell, tissue, Western blot, and co-immunoprecipitation workflows. This EDTA-free, DMSO-based formulation supports metal-sensitive assay chemistry while providing broad-spectrum control of proteolysis.
-
AMPK–SQSTM1 Feedback in Metabolic Stress
2026-09-08
This 2024 Autophagy study identifies a double-positive feedback loop in which AMPK and SQSTM1/p62 reinforce one another during metabolic stress, jointly activating NRF2 antioxidant defense and AMPK signaling. Its mechanistic model connects lysosomal deacidification, TFEB/TFE3 regulation, TAK1-dependent p62 phosphorylation, KEAP1 degradation, and AXIN–STK11–AMPK assembly, providing a framework for interpreting metabolic adaptation in lung cancer.